This study evaluates the clinical efficacy and cost-effectiveness of the ACQUIRE-ICD care innovation as add-on to usual care as compared to usual care alone in patients with an implantable cardioverter defibrillator.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
478
Information, guidance, supportive care, and psychological intervention
Gentofte Hospital
Gentofte Municipality, Hellerup, Denmark
Aalborg University Hospital
Aalborg, Denmark
Aarhus University Hospital
Aarhus, Denmark
Odense University Hospital
Odense, Denmark
Device acceptance
Measured with the Florida Patient Acceptance Survey (FPAS)
Time frame: 12 months
Health status (generic)
Measured with the Short Form Health Survey 12 items (SF-12)
Time frame: 12 and 24 months
Patient empowerment (ICD-EMPOWER)
Purpose-designed and disease-specific 14-item measure that measures patient empowerment
Time frame: 12 and 24 months
ICD patient concerns (ICDC)
8-item ICD Patients' Concern questionnaire that taps into fear of shock as reported by the patient
Time frame: 12 and 24 months
Symptoms of anxiety
Generalized Anxiety Disorder scale (GAD-7)
Time frame: 12 and 24 months
Symptoms of depression
Patient Health Questionnaire (PHQ-9)
Time frame: 12 and 24 months
Health status (heart failure specific)
Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
Time frame: 12 and 24 months
Return to work
Purpose-designed questions
Time frame: 12 and 24 months
Time to first ICD therapy
Defined as ATP, cardioversion or shock
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Zealand University Hospital - Roskilde
Roskilde, Denmark
Time frame: 12 and 24 months
Time to first hospitalization due to a cardiac cause
Hospitalization due to a cardiac cause
Time frame: 12 and 24 months
Time to mortality
Mortality
Time frame: 12 and 24 months
Cost-effectiveness
Incremental cost gained per quality adjusted life year (QALY) and burden on health care professionals (physicians and nurses)). This will be measured with the EQ-5D-5L or captured from the patient's electronic health record (EHR; e.g. number of phone calls, emails, and consultations with patients), and purpose-designed questions.
Time frame: 12 and 24 months